Peter Haeberli, JD


Merck & Co., Inc.

Peter Haeberli, J.D. joined Merck following the acquisition of Sirna Therapeutics Inc. in 2006.  At Sirna, Mr. Haeberli held the position of Director, Intellectual Property, where he was instrumental in the development of the company’s intellectual property estate.  Mr. Haeberli joined the predecessor to Sirna (Ribozyme Pharmaceuticals Inc.) in 1993 as a research chemist before transitioning to the legal department in 1999.  He held positions of increasing responsibility through the restructuring and relaunch of the company in 2003, leading up to the 2006 acquisition.  Prior to joining Ribozyme, Mr. Haeberli was a chemist with Ciba-Geigy Corp. in both Colorado and New Jersey.

Mr. Haeberli graduated from the University of Colorado, Boulder, with a B.A. in Molecular, Cellular, and Developmental Biology and received his J.D., Order of St. Ives, from the University of Denver, Sturm College of Law.  He is a member of the bar of the State of California and the State of Colorado, and is admitted to practice before the United States Patent and Trademark Office.